In agreement with our PCa data, FOXA1 OE resulted in a significant decrease while FOXA1 KO manifested in a significant increase of NR3C1 expression in bladder tumor organoids (Figure 6E). The gene discussed is NR3C1; the disease is urinary bladder neoplasm.